Medicine and Dentistry
Programmed Cell Death
100%
Prostate Carcinoma
100%
Carcinoma Cell
100%
3,4-Methylenedioxyamphetamine
100%
Radiosensitivity
100%
Prostate Cancer
75%
Polyethylene Glycol
66%
Promoter Region
58%
Cancer Cell
58%
Adenoviridae
58%
Tumor Cell
41%
Malignant Neoplasm
41%
Proteus Syndrome
16%
Gene Expression
16%
Nodular Melanoma
16%
Tumor Suppressor Gene
16%
Recurrent Disease
16%
Ionizing Radiation
16%
Clinical Trial
16%
Cancer Cell Line
8%
Neoplasm
8%
Fibroblast
8%
In Vitro
8%
Cancer Growth
8%
Carcinogenesis
8%
Radiosensitization
8%
Angiogenesis
8%
Antineoplastic Activity
8%
Cell Survival
8%
Cytokine
8%
Metastatic Carcinoma
8%
Tumor Xenograft
8%
Cancer
8%
Absence
8%
Gene Promoter
8%
Cell Death
8%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Carcinoma
100%
3,4 Methylenedioxyamphetamine
100%
Malignant Neoplasm
91%
Prostate Cancer
75%
Polyethylene Glycol
66%
Adenoviridae
58%
Neoplasm
50%
Clinical Trial
16%
Melanoma
16%
Tumor Suppressor Protein
16%
Ionizing Radiation
16%
Recurrent Disease
16%
Multiple Cancer
16%
Gene Delivery
8%
Nude Mouse
8%
Cytokine
8%
Cancer Growth
8%
Carcinogenesis
8%
Programmed Cell Death
8%
Absence
8%
Antitumor Activity
8%
Biochemistry, Genetics and Molecular Biology
Radiosensitivity
100%
3,4-Methylenedioxyamphetamine
100%
Cancer Cell
66%
Promoter Region
58%
Adenoviridae
58%
Clinical Trial
16%
Cell Death
16%
Tumor Suppressor Gene
16%
Gene Expression
16%
Animal Models
8%
Angiogenesis
8%
Radiosensitization
8%
Nude Mouse
8%
Carcinogenesis
8%
Cytokine
8%
Antineoplastic Activity
8%
Gene Promoter
8%
Cell Survival
8%
Fibroblast
8%